Induced sputum levels of soluble receptor ST-2 in adult patients suffering from allergic asthma or allergic rhinitis Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016
Cough sensitivity changes in allergic rhinitis and atopic dermatitis without clinical symptoms from lower airways Source: Eur Respir J 2002; 20: Suppl. 38, 188s Year: 2002
Inflammatory profile of patients with allergic asthma & rhinitis versus patients with allergic rhinitis alone Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients Year: 2007
Association of asthma control with allergic rhinitis severity in adult patients Source: International Congress 2019 – Asthma and allergies worldwide Year: 2019
Persistency of treatment response to omalizumab in patients with severe allergic (IgE-mediated) asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Treatment and outcomes in patients with asthma and allergic rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 576s Year: 2005
Improvements in asthma control and quality of life with omalizumab in allergic (IgE-mediated) asthma patients Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012
Perception of some aspect of asthma in Iranian asthmatic patients Source: Eur Respir J 2006; 28: Suppl. 50, 461s Year: 2006
Airway responsiveness in patients with cough variant asthma Source: Eur Respir J 2002; 20: Suppl. 38, 50s Year: 2002
Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients Source: International Congress 2015 – Asthma and lung immunology Year: 2015
Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009
Perception of asthma management quality by asthmatic patients Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007
Late Breaking Abstract - Efficacy of CSJ117 on allergen-induced asthmatic responses in mild atopic asthma patients Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020
Upper airways diseases in allergic and nonallergic asthma patients and nonasthmatic subjects Source: Eur Respir J 2004; 24: Suppl. 48, 589s Year: 2004
Follow-up of patients with moderate-severe allergic asthma treated with omalizumab Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010
Iron in serum and induced sputum of patients with allergic rhinitis and allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006
Asthma among allergic rhinitis patients Source: Eur Respir J 2003; 22: Suppl. 45, 108s Year: 2003
Efficacy of montelukast in patients with concomitan persistent allergic rhinitis and asthma Source: Eur Respir J 2006; 28: Suppl. 50, 663s Year: 2006
Allergic inflammation in serum and sputum: comparison between healthy controls and allergic asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 393s Year: 2004
Maximal airway response in patients with asthma and cough variant asthma Source: Annual Congress 2007 - COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis Year: 2007